QLINES Stock Overview
Engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Q-linea AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 4.78 |
52 Week High | SEK 8.10 |
52 Week Low | SEK 4.78 |
Beta | 1.05 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -80.96% |
3 Year Change | -96.95% |
5 Year Change | n/a |
Change since IPO | -91.52% |
Recent News & Updates
Recent updates
Shareholder Returns
QLINES | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | -2.3% | -2.2% |
1Y | -81.0% | -10.6% | 2.4% |
Return vs Industry: QLINES underperformed the UK Medical Equipment industry which returned -7.4% over the past year.
Return vs Market: QLINES underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
QLINES volatility | |
---|---|
QLINES Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.5% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: QLINES has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine QLINES's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 122 | Jonas Jarvius | qlinea.com |
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. It offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. The company serves healthcare providers.
Q-linea AB (publ) Fundamentals Summary
QLINES fundamental statistics | |
---|---|
Market cap | SEK 380.89m |
Earnings (TTM) | -SEK 238.80m |
Revenue (TTM) | SEK 6.32m |
60.2x
P/S Ratio-1.6x
P/E RatioIs QLINES overvalued?
See Fair Value and valuation analysisEarnings & Revenue
QLINES income statement (TTM) | |
---|---|
Revenue | SEK 6.32m |
Cost of Revenue | SEK 8.63m |
Gross Profit | -SEK 2.31m |
Other Expenses | SEK 236.49m |
Earnings | -SEK 238.80m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.04 |
Gross Margin | -36.53% |
Net Profit Margin | -3,776.69% |
Debt/Equity Ratio | 0% |
How did QLINES perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/11/18 13:14 |
End of Day Share Price | 2023/08/21 00:00 |
Earnings | 2023/09/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Q-linea AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
Ulrik Trattner | Carnegie Investment Bank AB |
Alexandru Cogut | Kempen & Co. NV |